| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Risk factors for hepatotoxicity associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: experience from three public health tuberculosis clinics. | Int J Tuberc Lung Dis | 2002 | 1.02 |
| 2 | Factors inhibiting use of the pneumococcal polysaccharide vaccine: a survey of Connecticut physicians. | Conn Med | 1998 | 0.77 |